Preleukapheresis risk factors for BCMA CAR-T product manufacturing failure
Blood Immunology & Cellular Therapy
· Elsevier
Аннотация
Publication date: September 2026 Source: Blood Immunology & Cellular Therapy, Volume 2, Issue 3 Author(s): Samantha Sparrow, Allyson Wolcott, Sarah Mott, James Davis, James McCollough, Hira Shaikh, Christopher Strouse
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицина»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Preleukapheresis risk factors for BCMA CAR-T product manufacturing failure. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000382?dgcid=rss_sd_all
Preleukapheresis risk factors for BCMA CAR-T product manufacturing failure. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000382?dgcid=rss_sd_all
“Preleukapheresis risk factors for BCMA CAR-T product manufacturing failure.” Blood Immunology & Cellular Therapy.
@article{article38477,
title = {Preleukapheresis risk factors for BCMA CAR-T product manufacturing failure},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000382?dgcid=rss_sd_all}
}